What is Anavex Life Sciences Corp (AVXL) stock price today?

Anavex Life Sciences Corp (AVXL) currently trades at $3.34 per share. The stock has a market capitalization of $309.52M and a P/E ratio of —x.

Is AVXL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Anavex Life Sciences Corp has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is —.

Is Anavex Life Sciences Corp financially healthy?

Anavex Life Sciences Corp's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of — places it in the —.

AVXL

Anavex Life Sciences Corp

NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY

$3.34

+2.45% today

Updated 2026-04-30

Market cap

$309.52M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.46

Dividend yield

—

52W range

$3 – $14

Volume

1.4M

Market cap

$309.52M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.46

Dividend yield

—

52W range

$3 – $14

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$22.00

+558.68%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-7.15M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-47.98M	$-47.49M	$-43.00M	$-46.38M	$-5.68M
EPS	—	—	—	—	$-0.46
Free cash flow	$-24.24M	$-27.79M	$-30.81M	$-39.04M	$-7.15M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-01-06	MISSLING, CHRISTOPHER U	Buy	125,000	—
2026-01-06	BOENISCH, SANDRA	Buy	12,500	—
2025-10-02	MISSLING, CHRISTOPHER U	Buy	125,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AVXL	$309.52M	25	4.3	3.0	5.0	6.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Anavex Life Sciences Corp trades at $3.34. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Anavex Life Sciences Corp's stock price?

Anavex Life Sciences Corp (AVXL) trades at $3.34.

Is Anavex Life Sciences Corp overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Anavex Life Sciences Corp (AVXL)?

The analyst target price is $22.00, representing +558.7% upside from the current price of $3.34.

Piotroski F-Score?

2/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-33.60%

Beta1.18

50D MA$3.86

200D MA$6.49

Shares out0.09B

Float0.09B

Short ratio—

Avg volume1.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AVXL vs LLY →AVXL vs JNJ →AVXL vs ABBV →Stock screener →